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Mycoplasma dispar is a capsulated mycoplasma that can cause chronic 
pneumonia in calves. The capsule of M. dispar exerts inhibitory effects on certain 
functions of bovine alveolar macrophages, specifically the production of tumor 
necrosis factor and interleukin 1, and glucose consumption. A 126 kDa protein, 
which we call capsule binding protein (CBP), has been observed to bind 
specifically to purified capsules of M. dispar. Polyclonal serum against capsule 
binding protein of M. disparwas made by immunizing rabbits with affinity purified 
CBP. Triton X-114 phase fractionation of mycoplasmas followed by analysis by 
SOS-PAGE and immunoblotting with the polyclonal serum identified that the CBP 
has hydrophobic fragments. Trypsin treatment of intact mycoplasma cells further 
demonstrated that CBP was a membrane-associated protein. Trypsin treatment 
of intact cells also generated a 66 kDa protein fragment that could bind to M. 
dispar capsules. Carboxypeptidase Y treatment of intact mycoplasma showed 
that CBP could be cleaved by this enzyme. This demonstrated that the C-terminal 
end of the CBP is on the outside of M. dispar cells. This protein may be similar to 
other C-terminal- exposed proteins of prokaryotes with binding properties, or may 
have other functions beyond its currently demonstrated binding properties such 
as the streptococcal glycosyltransferases which have binding and synthase 
activities in separate external domains. 
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INTRODUCTION 
Mycoplasma dispar (M. dispar} was first isolated and characterized in England 
(48 , 49). It has since been one of the most frequently isolated mycoplasmas from 
pneumonic lungs of calves in Eng land (49), Australia (1 44), USA (12), Japan (79) 
and Denmark (99). This mycoplasma appears to be a common inhabitant of the 
respiratory tract of healthy and diseased calves (49, 161 , 12, 99 , 153). The 
pathogenicity of M. dispar has been established by experiments in gnotobiotic 
calves (64, 50), by inoculations into the bovine mammary gland (17) , in vitro by 
experiments on tracheal organ cultures (160) and also by epidemiological 
evidence (120, 153). Experimental studies (152) have demonstrated that M. 
dispar, when allowed to infect young calves naturally, effectively and extensively 
colonized their respiratory tract. The colonization was not on ly restricted to the 
upper parts of the respiratory tract but also involved the tracheobronchial tree. M. 
disparcells were restricted to the margin of the ciliated epithelium (162). There 
they caused alterations of the ci liary apparatus which include degeneration of the 
respiratory epithelial cells and loss of the ciliary activity. It was also demonstrated 
that M. dispar could impair lung clearance of other bacteria (5). M. dispar rarely 
causes mortality by itself, but it is very important as a primary or concurrent agent 
of pneumonic infection in cattle (164, 35). 
Experiments (63) with M. dispar have shown that the immune response of 
young calves to M. dispar is defective and it is unlikely to be entirely due to a 
general immaturity of the immune system of the calves since the response to M. 
bovis was not reduced to the same extent. It was also demonstrated that this 
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mycoplasma species could induce immunosuppression when injected in 
combination with other antigens and exerted an inhibitory effect on the mixed 
lymphocyte response to mitogens (30). It was suggested that this suppressive 
effect could be related to the avidity with which this mycoplasma species adhered 
to the host cell membrane, resulting in alteration in the membrane/receptor 
structures on the host cell and the production of a suppressive factor. 
M. disparwas shown to produce a capsule in vitro, which could be visualized 
by electron microscopy following reaction with ruthenium red (62). The capsule of 
M. dispar posseses no obvious structure and extends for 17 to 24 nm beyond the 
cytoplastic membrane. Further studies confirmed that M. dispar does produce 
capsule in vivo, i. e. in infected calves, and that such capsules share antigenic 
determinants with capsules produced by this mycoplasma under in vitro 
conditions (4). The chemical composition of the capsules is a polymer of 
galactose and galacturonic acid (9). 
Recently, it was demonstrated that encapsulated M. disparor even purified M. 
disparcapsule exerted inhibitory effects on certain functions of bovine alveolar 
macrophages, specifically the production of tumor necrosis factor and interleukin 
I, and reduced glucose consumption (6). It is assumed that the antiphagocytic 
activity of M. dispar may enable the organism to evade phagocytosis in vivo , 
leading to a tendency towards a chronic infection in calves. 
A 126 kDa protein (we call this protein capsule-binding protein , CSP) of M. 
disparthat can be radio-labeled with 35S-methionine was shown to be co-
regulated with capsule production , increasing in abundance as capsule is 
expressed. This CBP was also shown to have capsule-binding properties , since it 
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could be captured from M. dispar lysates by beads covered with purified M. 
disparcapsule (Rosenbusch, R., personal communication) . A common 
mechanism of capsule production among gram positive Streptococcus species is 
the use of glucosyltransferase enzymes. These proteins have polysaccharide-
synthesis and binding properties (80, 93 , 94, 186). Because mycoplasma and 
streptococci evolved from a common ancestor (185, 119, 180), they may share 
some similarity in capsule production and capsule binding. Therefore, we 
presume that the 126 kDa protein may be associated with capsule production 
and may well have both a capsule-binding and a catalytic domain. 
The main objective of this research project is to characterize this 126 kDa 
protein to see if the protein is a membrane integrated protein and its C-terminus 
is external, and to locate its capsule binding domain. 
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LITERATURE REVIEW 
This literature review includes three parts : a general review of mycoplasma, a 
general review of capsule, and a review focused on the advances in capsule 
binding protein (CSP). 
Mycoplasmas 
The term "mycoplasmas" has been used rather loosely to denote any species 
in the class Mollicutes, whereas the terms acholeplasmas, ureaplasmas, 
spiroplasmas, anaeroplasmas, and asteroleplasmas are used when reference is 
made to specific members in the corresponding genera. So the name Mollicutes 
is suggested to be a common name for any member of the class. Nevertheless, 
"mycoplasmas" is still widely used in its broader sense {146). 
The mycoplasmas are the smallest self-replicating prokaryotes (110). The 
single most important characteristic that distinguishes the mycoplasmas from 
other prokaryotes is their total lack of a cell wall (145). These organisms can filter 
through 450 nm pore diameter filters and produce minute colonies with typical 
fried-egg appearance in the case of most species. 
Mycoplasmas usually exhibit an extremely simple ultrastructure. The 
mycoplasma cell is bounded by a plasma membrane and the enclosed cytoplasm 
contains ribosomes and a circular double-stranded DNA molecule. And the 
minute mycoplasma cells contain only the minimum sets of organelles and 
metabolic pathways essential for cellular growth and replication. The 
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mycoplasma genome is typically prokaryotic (185). However, the size of the 
Mycoplasma and Ureapfasma genome (500 to 800 kbp) is the smallest recorded 
for any self-replicating prokaryote, being approximately one-sixth the size of the 
Escherichia coli genome and approximately one-half the size of the genome of 
Rickettsia, while the organisms in the other mycoplasma genera are considered 
to have genomes double this size (1 12, 11 3). The mycoplasmas have an 
extremely low G+C content of mycoplasmal DNA. With very few exceptions the 
G+C content of mycoplasma genomes is within the range of 24 to 30 mole% 
(185). 
The basis for the current classification system was established by Edward and 
Freundt (27). Classification of an organism within the class Mofficutes depends 
primarily on absence of a cell wall , filterability through a membrane fi lter of 450 
nm diameter and production of minute colonies with fried-egg appearance. 
Subdivision of orders within this class is based on nutritional and morphologic 
criteria. Molecular tools in taxonomy include genome size, genomic base 
composition and DNA modification, DNA-DNA hybridization , cleavage patterns 
and genomic maps and specific genomic sequences (34). The class Mofficutes 
has three orders. Order I is Mycopfasmatales which has two families. Family I is 
Mycoplasmataceae, containing two genera. They are Mycoplasma and 
Ureaplasma. Differentiation between these two established genera depends on 
the capability of members of Ureaplasma to hydrolyze urea, with the production 
of ammonia and C02 {128). Family II is Spiroplasmataceae with one genus, 
Spiroplasma. Order II is Acholeplasmatales. It has one family , 
Acholep/asmataceae, and this family has one genus, Acholeplasma. Order Ill is 
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Anaeroplasmatales. It has one family , Anaeroplasmataceae, and this family has 
two genera, Anaeroplasma and Asteroleplasma. There are also some 
mycoplasma-like organisms that are not cultivable and remain unclassified. 
Almost all of the mycoplasmas are parasites of man, animals, anthropods, and 
plants. Although some mycoplasmas are commensals and belong to the normal 
flora, most species are pathogens. Mycoplasmas are distributed widely 
throughout the animal kingdom. Despite their ubiquitousness, mycoplasmas 
usually exhibit a rather strict host and tissue specificity (111 ). The customary 
habitat of the organisms in animal hosts is mucous membrane surfaces; 
accordingly they may be found in the respiratory, gastrointestinal and urogenital 
tracts. They can also be found in serosal surfaces such as those of joints. Many 
of the diseases caused by the mycoplasmas are chronic, life-long and difficult to 
cure (178). 
In the past three decades several models for mycoplasma evolution have 
been formulated. Neimark (101 , 102, 103) proposed that mycoplasmas were 
polyphyletic and presumably had arisen by degenerate evolution. According to 
this model, the mycoplasma would have arisen after evolution and diversification 
of the bacteria and different species are not phylogenetically related; instead, 
they would originate from different branches of the bacterial phylogenetic trees. 
Another model was proposed by Morowitz and Wallace (96, 179). In this model, 
mycoplasma was thought to arise very early in the evolution of living forms and 
be the precursors of the bacteria. But based on the SS and 16S rRNA sequence, 
Woese, Maniloff, and coworkers demonstrated that none of these two models 
was correct (89 , 185). Therefore , they proposed another model (185). In this 
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model, the basic ideas are: (i) the mycoplasmas are monophyletic, (i i) the 
mycoplasmas are from a branch of the gram-positive bacteria with DNAs having 
low G+C contents, and (iii) the evolution rate of the mycoplasma is fast. This 
model was confirmed and improved by subsequent studies (1 19, 180, 85) . The 
mycoplasma phylogenetic order is Asteroleplasma, Anaeroplasma and 
Acholeplasma, Spiroplasma, Mycoplasma, and Ureaplasma. Although the 
mycoplasma phylogenetic tree is monophyletic, species currently included in the 
genus Mycoplasma are polyphyletic, having originated as three independent 
branches from the Spiroplasma branch (88). Mycoplasmas are evolving about 
50% more rapidly than the Lactobacillus group, from which the mycoplasmas 
arose (184). The Lactobacillus group contains Lactobacillus, Bacillus, and 
Streptococcus species and two unusual Clostridium species, Clostridium 
innocuum and Clostridium ramosum. Many properties of the mycoplasmas were 
shown to be more similar to the same properties in gram-positive bacteria (e.g., 
Bacillus subtilis) than in gram-negative bacteria (e.g., Escherichia co/1) . These 
properties include lipid composition (127, 142) , SS rRNA sequences (177), tRNA 
sequences (117, 176), tRNA gene organization (118, 117) , tRNA and rRNA 
methylation patterns (65), features of aromatic amino acid metabolism (11 ), 
specific transport systems (46), and PPi-dependent enzymes (106). C. innocuum 
and C. ramosum were also shown to be phylogenetically related to the 
mycoplasmas (119 , 180, 185). Neimark and London (103) found that sterol-
nonrequiring mycoplasmas evolved from streptococci. Most recently , Fraser et al. 
(33) got the complete nucleotide sequence of the Mycoplasma genitalium 
genome and compared this genome to that of H. influenzae. The M. genitalium 
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genome contains 90 putatively identified genes that do not appear to be present 
in H. influenzae. But almost 60% of these genes have database matches to 
known or hypothetical proteins from gram-positive bacteria and other 
Mycoplasma species. They also found differences in gene transcription, protein 
transport, sugar consumption as energy source, and regulatory systems between 
them. These differences suggest that M. genitalium and H. influenzae are not 
phylogenetically related. Hence, the Lactobacillus group and the mycoplasmas 
had a common ancestor and the connection between them should have some 
biological implications. 
The model of mycoplasma phylogeny constructed by Weese, Maniloff, and 
coworkers is now partially accepted (88) and the knowledge about the 
mycoplasma phylogeny gives us a better understanding of mycoplasma biology. 
Microbial Capsule 
All living cells are surrounded by complex carbohydrates (68). On eukaryotic 
cells, many different carbohydrates are attached as glycoproteins and glycolipids, 
which play a role in cell-cell or cell-ligand interactions and which are frequently 
also interacting with extracellular matrix. Polysaccharide capsules of prokaryotes 
characteristically composed of repeating oligosaccharides, are fou nd on the 
surface of many bacteria. Both gram-negative and gram-positive bacteria 
frequently produce capsules. These capsules are commonly composed of only 
one type of polysaccharide and lie outside the outer membrane of gram-negative 
cells and the peptidoglycan layer of gram-positive cells (68). Capsules or 
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capsule-like structures have also been described among several mollicute 
species. These include Mycoplasma mycoides subsp. mycoides (18)], 
Mycoplasma dispar (62) , Mycoplasma gallisepticum (159) , Mycoplasma hominis 
(37), Mycoplasma hyponeumoniae (151 ), Mycoplasma meleagridis (51 ), 
Mycoplasma pneumoniae (183), Mycoplasma pulmonis (159) and Mycoplasma 
synoviae (3). Among the ureaplasmas, the human pathogen Ureaplasma 
urealyticum expresses capsule (116). 
Both capsule and slime are bacterial extracellular polysaccharides. But there 
are differences between them. As a capsule the polysaccharide is intimately 
associated with the cell surface and may be covalently bound. In contrast, slime 
polysaccharides are only loosely associated with the cell surface (149). 
Distinction between capsule and slime polysaccharides is often operationally 
defined by the degree of cell association following centrifugation. Differentiation 
between the two forms may be difficult, since cells producing large amounts of 
capsule polysacharides may "release" some material at the periphery, giving the 
appearance of slime production. Mutations from capsule to slime production are 
known to occur. Most bacteria show a preference for producing one form over 
another, although some strains of Klebsiella sp. can simultaneously produce 
chemically identical capsule and slime. Several bacteria, including strains of 
Rhizobium sp., Agrobacterium sp., and Alcaligenes faecalis var. myxogenes are 
able to synthesize more than one chemically distinct exopolymer (149). 
Capsules are viscous pliable structures, which are hydrophilic and confer a 
negative charge on the bacterial cells (107, 170). Composed of 99% water, these 
highly hydrated, polyanionic polysaccharide capsules serve many functions. 
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These include determining access of molecules and ions to the bacterial cell 
envelope and the cytoplasmic membrane, the promotion of adherence to the 
surfaces of inanimate objects or living cells and the formation of biofilms and 
microcolonies (23). Among certain bacteria, capsules have evolved distinctive 
structural and functional characteristics which are of cardinal importance in the 
pathogenesis of infections of animals, humans, plants and insects (147). 
Bacterial capsules can be divided into groups based on their chemistry and 
the conditions under which they are synthesized {148). They may be linear 
homopolymers of a single chemical substrate, i.e. they are formed entirely of one 
monosaccharide type. They can be linear heteropolymers, which are composed 
of two or more monosaccharides. Or they can be multichained or branched 
polymers composed of two to five monosaccharides and additional moieties (83). 
Structural diversity arises from a broad range of monosaccharide components 
and is increased by potential noncarbohydrate substituents and linkage types 
(71 ). 
The sugar components of capsules can be identified by direct chemical 
analysis. Some components such as 0-glucose, 0-mannose, 0-galactose and 0 -
glucuronic acid occur very frequently , others such as L-rhamnose or L-fucose are 
slightly less common, 0-mannuronic acid and L-guluronic acid are rare {148). 
The production of capsules by the bacterial cell is a very complex process, 
passing through stages which are associated with different ce llular 
compartments. This process begins with the synthesis of the sugar components 
of the polysaccharides and their activation by conversion to nucleotide derivatives 
(31 , 182). Nucleotide diphosphate sugars, or more rarely, nucleotide 
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monophosphate sugars serve as activated donors (1 67). The enzymes involved 
in synthesis of the precursors are cytoplasmic, but may in some cases be loosely 
associated with the cytoplasmic membrane (1 50). The subsequent 
polymerization is catalyzed by an inner membrane bound transferase complex. 
These transferases are poorly defined, with an unknown number of components 
and a catalytic mechanism which remains obscure (67, i 49, 165, 167). But some 
neutral polysaccharides produced by gram-positive cocci, such as the levans and 
glucans, are synthesized from sucrose on the outer surface of the prokaryotic 
membrane (148) . 
Polymerization is generally believed to involve a lipid carrier. The lipid involved 
may be undecaprenol phosphate on which monosaccharides or oligosaccharides 
are assembled. The precise role played by the lipid is presently unknown (1 0) . 
Some possibilities include facilitating the structure and ordered formation of the 
repeating unit structure, solubilization of hydrophilic oligosaccharides in a 
hydrophobic membrane domain, transport across the membrane, regulation of 
priorities in polysaccharide synthesis on the basis of lipid availability, or a 
combination of these events (148, 167). The final polymer is transferred from the 
lipid carrier to an endogenous acceptor (141 , 167). It is suggested that the 
acceptor has phospholipid and this phospholipid may function as an anchor for 
extracellular polysaccharides in the outer membrane (47, 126). The export of 
capsular polysaccharide consists of at least two stages, viz., the translocation 
across the cytoplasmic membrane and subsequent transport to the cell surface 
(31 ). The final step is the organization of polysaccharide into a capsule. The 
translocation and the organization is very poorly defined. The regulation of 
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capsule synthesis, involving either plasmid, or chromosomal genes, or both, has 
been the subject of a series of studies (90). In Rhizobium meliloti, capsule genes 
are divided between the chromosome and the megaplasmid pRmeSU47b (84), 
but in most other bacteria the determinants are chromosomal. In E. coli K1 , the 
capsule genes are clustered at the kps locus. The genes determining the 
expression of E. coli group I and group II capsular polysaccharides are located at 
different sites on the bacterial chromosome (105, 171 ). It was shown that these 
gene clusters do not hybridize in vitro. Recent advances in the genetic analysis 
of group 11 and related capsules, especially with E. coli, N. meningitidis, and H. 
influenzae (14, 15, 77, 78, 131 , 143, 173) have revealed the organization and 
function of these capsule genes. It was found that the capsule genes of E. coli 
are organized in three regions. The central region 2 directs the polymerization of 
the respective capsular polysaccharide; it is thus specific for a given capsule ; 
region 2 is flanked by region 3, which directs the translocation of the 
polysaccharide across the cytoplasmic membrane, and region 1, which directs 
the transport through the periplasm and the outer membrane into capsular 
compartment. Both region 1 and 3, which serve general functions, can be 
exchanged between different E. coli with group II capsules. It was found later that 
region 1 also encodes other functions than those of transport. In other bacteria 
such as Xanthomonas campestris (57, 163), the capsule genes may be 
organized into more than one cluster. Recombinant DNA technology has helped 
resolve the basis for genetic instability of the capsule trait in some bacteria. In H. 
influenzae type b, capsule genes are present as a tandem repeat. Homologous 
recombination events resulting in the loss of one copy of the genes may lead to 
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the appearance of unencapsulated bacteria (59). 
Control of precursor availability by either feedback inhibition (76) or 
degradation (172) have been reported. Regulation of capsular synthesis at the 
level of lipid intermediate availability has also been proposed (148). For the most 
part, however, regulatory elements acting on capsular synthesis have not been 
defined. 
Capsules have long been associated with virulence properties of bacteria. 
More recently it has been possible to define at the molecular level many of the 
mechanisms involved in the virulence provided by bacterial capsules. 
Most capsular polysaccharides are hydrophilic and confer a negative charge 
on the bacterial cell, characteristics which are intrinsically antiphagocytic in their 
effect. It is argued (107, 170) that the hydrophilic properties of polysaccharide 
capsules act by reducing the surface tension at the interface between the 
phagocytic cell and the bacterium and that this impairs the ease with which 
phagocytic ingestion occurs. Considering surface charge, it seems reasonable 
that contact between capsulated bacteria and phagocytic cells would be 
compromised since the net negative charge on each would tend to result in 
mutual repulsion. 
The interaction of bacterial capsules with the complement system is an 
important mechanism with which tissue-invasive bacteria can evade the 
nonspecific host defenses. As far as we know today, it is the interference of 
capsular polysaccharides with regulatory proteins that upsets complement action. 
A pivotal compound, joining both pathways, is factor C3. Its conversion to the 
active form C3b is activated by the classical convertase C2bC4b, which is under 
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the control of a C4 binding protein, C4bp (104). Some capsular polysaccharides 
appear to bind C4bp and thus interrupt the complement cascade {24). Activation 
of the central component C3 to C3b by the alternative pathway is controlled, inter 
alia, by factors Band H. These regulate the affinity of C3b to bacterial cell 
systems. Some capsules decrease the affinity of factor B to C3b and others 
increase its affinity to factor H (24, 87). In both cases, the surface deposition of 
complement is decreased and the encapsulated bacteria escape the bactericidal 
activity of the complement system. A somewhat simpler interpretation , which may 
be given in addition to the above, is that encapsulated bacteria bind the 
complement components too far away from the cell surface to be harmful (122, 
24). 
Although bacterial capsu les generally induce the formation of anticapsu lar 
antibodies, which activate host defenses, their immunogenicity is often age 
related (115). Thus, many encapsulated bacteria are not immunogenic in 
newborns or young children (69). In general, infants aged less than about 2 years 
possess low or are absent concentrations of anticapsular antibodies even 
following recovery from systemic infection with capsulated bacteria. The reason 
for the delay in the ability to respond to capsular polysaccharides is due to the 
delayed maturation of Lyb-5 B cells. It is generally argued that young infants in 
whom clearance of tissue-invasive bacteria is least efficient face a period of 
heightened susceptibility starting from the point at which levels of maternally 
acquired antibodies decline at about 3 months until the latter half of the second 
year, when the ability to mount endogenous, type-specific antibodies against 
polysaccharide antigens matures. 
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Certain bacterial capsules are not or only poorly immunogenic also in adults. 
Structural elucidation of these capsules has revealed that this is due to identity of 
the capsules with certain substances found in the host. For example, The K1 
capsular polysaccharide of E. coli, a poly-a-2,8-sialic acid, has the same 
structure as the carbohydrate terminus of the embryonic neural cell adhesion 
molecule n-CAM (32). By the same token, the E. coli KS capsular polysaccharide, 
a heteropolysaccharide consisting of 4-~-glucuronic acid and 4-a-N-
acetylgluosamine (169) , is identical with the first polymeric intermediate of 
heparin (100). These findings emphasize that capsules counteract host defenses 
not only by interaction with complement components but also by evasion of 
immune recognition owing to molecular mimicry. 
Finally, the shedding of capsule from the bacterial surface is a potential 
mechanism for jettisoning attached host factors or for nullifying the functional ro le 
of circulating host factors such as type-specific antibodies {97). 
Polysaccharide Binding Proteins 
Proteins and enzymes that bind carbohydrates are present in large numbers 
in all living cells and are involved in a myriad of important biological functions 
{109). This abundance is primarily due to the fact that carbohydrates derived from 
carbon dioxide fixation constitute the bulk of the organic matter on the earth , and 
together with their various derivatives and polymeric forms are utilized for many 
essential purposes in the cell. For example, prokaryotic capsules that are 
polysaccharides play a very important role in the survival of bacteria in their 
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hosts. Some proteins bound to capsular polysaccharide are shown to be 
associated with capsule production. Currently, most of the references 
about CBP are focused on the glycosyltransferase enzymes of gram-positive 
cocci that have polysaccharide-synthesis and binding activities. Therefore th is 
review is mainly focused on the general properties of these enzymes. in addit ion , 
there will also be a short review about glucan-binding proteins. 
GI ucosyltransferases 
Streptococcus mutans and its related oral streptococci are microorganisms 
that synthesize adherent water-soluble and/or water-insoluble glucans from 
sucrose by glucosyltransferases (GTFs). The complex polysaccharides have 
been considered important for colonization of the bacteria on tooth surfaces (53, 
98), which promotes enamel demineralization and attendant dental caries (86). It 
was first shown by Guggenheim & Newbrun (52) that a single strain cou ld 
produce a number of electrophoretically distinct GTFs. Ciardi et al. (22) showed 
that some of these enzymes synthesized soluble polymers and others 
synthesized insoluble polymers. Since then several laboratories have isolated 
and characterized multiple GTFs from various Streptococcus mutans strains (38 , 
45 , 129, 189). These GTFs are generally classified into three groups: GTF-1 , 
which produces a water-insoluble, primarily a.-1 ,3-linked glucan ; GTF-S, which 
produces a water-soluble, primarily a.-1 ,6-linked glucan; and GTF-SI which 
produce a combination of water-soluble and -insoluble glucans (44). In S . 
mutans, GTFs are encoded by three genes, gtfB, gtfC, and gtfD, which express 
different enzyme activities: gtfB encodes GTF-1, gtfC encodes GTF-SI , and gtfD 
encodes GTF-S (7, 36, 55 , 56) . The insoluble glucan produced primarily by GTF-1 
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and GTF-SI mediates the sucrose-dependent attachment of S. mutans to the 
smooth surfaces (53) . The contribution of the water-soluble glucan to the dental 
caries process is unknown, but it causes aggregation of certain bacteria and can 
serve as an extracellular energy store (44). Generally, GTF-S is found in the 
culture medium and GTF-1 is cell associated (57). GTF-1 and GTF-SI have a high 
degree of amino acid sequence identity (19). But GTF-1 and GTF-S, which 
synthesize distinct glucan products, are also structurally different from each other 
(92, 129, 133). However, since GTFs catalyze similar processes involved in 
glucan synthesis, it is likely they share many structural features relevant to the 
catalysis. Although the pathway of glucan synthesis is incompletely determined, 
several investigators have suggested that GTF protein is composed of domain 
structures bearing distinct functions, such as glucosyl transfer and glucan 
binding(28, 7 4, 93). 
The binding potential of GTF to glucans is suggested by several studies (40, 
53, 91 ). In the meantime, the structure and function of GTFs have been studied 
by biochemical and recombinant DNA techniques. Ferretti et al. (28) were the first 
to determine the complete nucleotide sequence of the GTF-1 gene from a strain 
of Streptococcus sobrinus (MFe28} and have located a glucan-binding site by 
deletion analysis of Gtf-1 in the carboxy-terminal region of the GTF-1 protein , 
which is essential for the enzyme activity. Furthermore, Mooser and Wong (93) 
isolated a glucan-binding fragment from a trypsin digest of GTF-S and Kobayashi 
et al. (75) also isolated a 55 kDa peptide from a trypsin digest of GTF-1 which has 
a glucan-binding domain. These observations indicate that both GTF-1 and GTF-
S proteins contain a structural domain which functions in glucan binding. The 
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location of the glucan binding region in GTF-1 has been narrowed to the C-
terminal one third of the enzyme (28). These glucan-binding domains are 
composed of a series of repeated sequences that have been classified into four 
different classes (A-0) by virtue of sequence similarity and which , by inference, 
have been suggested to be of functional importance (1, 8, 28, 41 , 42 , 43, 44, 60 , 
130, 168). Recently, a relationship between these repeats and those of the 
ligand-binding repeats of toxins A and B of Clostridium difficile, a glucan-binding 
protein (GBP) from S. mutans and the lysins of Streptococcus pneumoniae have 
been observed both immunologically and at the amino acids sequence level (44, 
139, 186, 187) , suggesting that sequences of this type may play a role in the 
biology and/or pathogenicity of a range of Gram-positive bacteria. The glucan-
binding proteins (GBP) from S. mutans contain two sets of non-adjacent repeats 
(5.5 A and 4 C repeats) which span almost the entire length of the protein (8) 
(Note: two series of repeats were identified within the GBP and were designated 
A and C repeats; the A repeats were represented by five regions of 32 to 34 
amino acids, with a partial sixth repeat of 12 amino acids at the C terminus of the 
protein , hence 5.5 A ; the C repeats ranged from 17 to 20 amino acids and 
occurred four times throughout the protein sequence.). The toxin A class II B-
repeat consensus sequence shares 14 of 16 consecutive residues with the 
consensus class A repeats from GBP (186). Amino acid repeats similar to the 
class A and C repeats of S. mutans GBP also occur in GTF enzymes. Genes for 
four enzymes have been sequenced: two are from S. mutans GTF-B (6 A and 5 
C repeats) (130) and GTF-C (3.5 A and 2 C repeats) (168) and two are from 
Streptococcus downei, GTF-1 (6 A and 5 C repeats) (28) and GTF-S (4.5 A and 4 
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C repeats) (44). Russell (123) has suggested that an appropriate sing le-base 
frameshift in the termination codon of the gene sequence reported for GTF-C 
results in 5 A and 3 C repeats. The A and C repeats show little similarity to each 
other and the relative positions of the C repeats vary between the GBP and GTF. 
The comparison of the amino acid sequences of all group A repeats from the 
GBP, GTF, and those of the two clostridial toxins reveals that three amino acids 
are conserved in almost all cases, the tyrosine-phenylalanine dipeptide, and a 
glycine 10 residues upstream of the tyrosine-phenylalanine dipeptide (1 86). 
Aromatic residues (tyrosine, phenylalanine and tryptophan) are generally 
conserved at certain other positions, particularly in the two positions just 
upstream of the tyrosine-phenylalanine dipeptide. Charged and polar residues 
(particularly lysine, glycine and threonine) intermingled with turn-promoting 
residues (praline, glycine, asparagine and serine) predominate at other sites 
with in the repeats. These repeats favor the protein-polysaccharide complexes of 
GTF. 
The analysis of glucosyltransferase glucan-binding regions and related 
sequences by Giffard et al. (43) extends these previous studies by defining a 
fundamentally conserved repeating motif that transcends the boundaries of all 
previously designated repeat structures that have been found in the related 
carboxyl-terminal ligand-binding domains of streptococcal GTFs, C. difficile toxin 
A, and S. pneumoniae autolysin , as well as glucan-binding protein. Results have 
shown that while in any given GTF-pair these motifs may posses a wide range of 
similarity, certain residues are highly conserved. A common rationale used by 
workers for classification of repeats into different classes is that this may aid in 
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accounting for differences in the binding properties of the ligand-binding domains 
from different enzymes. 
The glucan-binding domain has been cloned, proteolytically excised from the 
native enzyme and partly characterized. In contrast, there is much less work 
reported about the catalytic domains of the GTFs. The location of the catalytic 
sites was done by deleting amino acids from the N-terminal region . The study of 
GTF-1 from S. sobrinus showed that the N-terminal 80 amino acids were 
nonessential for enzymatic activity. However, the loss of 260 amino acids from 
the N-terminus of GTF-1 by further deletion diminished the enzymatic activities for 
sucrose splitting and glucan synthesis, although glucan binding was not affected 
because of an intact C-terminus (1 ). Furthermore, it has been shown that 
antiserum to a chimeric protein composed of 15 amino acids of the N-terminus of 
GTFB (residues 342 to 356) inhibited the water-insoluble glucan synthesis of a 
crude enzyme prepared from a culture supernatant of S. mutants GS-5 (25). 
Then, an active site responsible for sucrose binding was proposed after 
sequencing of a peptide from the stabilized glucosyl-enzyme complex (94, 95) 
and confirmed by site-directed mutagenesis (70) . This peptide of nine amino 
acids is located in the N-terminal one-third of the GTFs. Together, these results 
suggested that the N terminus of the GTFs may play a central role in the 
enzymatic activities for sucrose splitting and glucan synthesis. 
An amino-terminal region of approximately 40 residues extending from 
positions 387 to 427 of GtfB (or 413 to 453 of GtfC) was identified to be highly 
conserved among the GTFs of several streptococci (21 ). Furthermore, the DNA 
sequence variations in this region did not alter the amino acid sequence (20), 
21 
suggesting some biological importance of this conservation . A 19-amino-acid 
peptide containing residues 435 to 453 of GtfC was able to reverse the inhibitory 
effect of a polyclonal antibody which neutralized GTF enzymatic activities (20). 
Monoclonal antibodies against the 19-amino-acid peptide recognized the 
conserved region and inhibited insoluble glucan synthesis by GtfC and the 
attachment of S. mutans to glass surfaces (19). These results indicate that the N-
terminal conserved region of a GTF is functionally important for both enzymatic 
activity and bacterial adherence. 
It has recently been suggested that intra- and interspecies variation between 
streptococcal enzymes may be an ongoing process that could circumvent the 
idea of using conserved epitopes as immunogens (43). Because of the central 
role that GTFs play in dental plaque formation , they have been considered as 
potential components of a dental caries vaccine (154). Experiments with animal 
models and with humans have supported this potential. For example , GTFs from 
S. sobrinus and S. mutans of the mutans streptococci have been demonstrated 
to elicit immune responses which are protective against experimental caries 
caused by infection with several mutans streptococcal species (136, 137, 155). 
The salivary immunoglobulin A (lgA) antibody response to oral and/or local 
administration of GTFs to humans has been significantly correlated with 
interference with reaccumulation of indigenous mutans streptococci (134, 138). 
Although the basis for experimental protection with GTF-based vaccines is 
unknown, it is likely to involve antibody mediated inhibition of the catalytic and/or 
the glucan-binding activity of GTF (157, 158). Although antibody binding to 
functionally important domains may not be necessary theoretically to achieve 
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immunological protection , binding to catalytic domains should result in loss of 
enzyme activity. Antibody-mediated inhibition of these functional activities has 
been demonstrated (157, 158).The peptide DANFDSIRVDAVDNVDADLLQ 
(CAT) contains an aspartic acid that has been implicated in an early catalytic step 
of glucan synthesis (94, 95). Rat serum antibody and mouse lgM MAb to this 
peptide significantly inhibited the ability of S. sobrinus GTF to synthesize glucan 
(140). The immunogenicity and antigenicity of a multiply antigenic peptide 
construct containing four copies of the synthetic peptide 
TGAQTIKGQKL YFKANGQQVKG (GLU) were measured in rodents and humans 
(139). This peptide sequence was derived from a pattern of repeating sequences 
which have been identified in the C-terminal in all GTFs from mutans streptococci 
and have been associated with glucan binding properties of GTF (1, 29, 53 , 56 , 
86). Antibody to this construct reacted with native GTF of both S. sobrinus and S. 
mutans and inhibited its function. This antibody could also modify colonization of 
the oral cavity by mutans streptococci in ways other than by enzyme inhibition. 
Taubman et al. (156) demonstrated that immunization of rats with peptide 
constructs GLU and CAT resulted in significantly reduced smooth surface and 
sulcal caries after infection with S. sobrinus. Thus, antibody to epitopes present in 
the N-terminal and C-terminal domain regions of GTF apparently can interfere 
with enzyme function. In addition, Dertzbaugh and Macrina (25) have 
demonstrated inhibition of GTF activity with antibody to a chimeric peptide that 
included a sequence closer to the N terminus (residues 342 to 356) than the CAT 
sequence (residues 487 to 507) in S. mutans (60, 168). Also, Chia and coworkers 
{20) have synthesized a 19-mer peptide, homologous to a sequence nearly 
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adjacent to the CAT region, that contained an epitope able to remove some of the 
GTF-inhibitory activity of polyclonal antibodies directed to S. mutans GTF-8 and 
GTF-C. These observations suggest that inhibition of GTF activity can be 
achieved by the binding of antibody to sequences that may not necessarily be 
associated with function. 
The above mentioned studies suggest that subunit vaccines that are based 
on GTF sequences have the potential to modify dental caries caused by mutans 
streptococci. Antibody-mediated inhibition of the caries process could be 
achieved by interference with GTF catalytic activity, by modification of the nature 
of the glucan product, or by agglutination of microorganisms through bacterial cell 
surface GTF epitopes. The success of such a vaccine strategy is predicated on 
the incorporation of an appropriate peptide into a carrier construct that results in 
an effective immune response. 
In summary, GTFs have been implicated as one of the virulence factors in the 
pathogenicity of mutans streptococci. GTFs can synthesize glucans from sucrose 
and concomitantly bind these glucans. This ability of GTFs is thought to 
contribute to cell adherence and accumulation on tooth surfaces. GTFs have 
glucan-binding domains, which are located in the C-terminal one-third of the 
GTFs, and catalytic domains, which are located in the N-terminal one-third of the 
GTFs. The antibodies against fragments bearing these domains are 
demonstrated to protect the tooth from forming dental plaque. GTFs are potential 
vaccine candidates. 
Glucan-Binding Proteins (GBP) 
In addition to the GTFs, there is another group of proteins synthesized by 
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mutans streptococci that can also bind glucans. This group of proteins are called 
glucan-binding proteins, and they do not have GTF enzymatic activity. 
Several GBPs of different molecular weights have been reported. Russell 
(124) isolated a 74-kDa GBP from the extracellular fluid of cultures of S. mutans 
serotype C. Landale and McCabe (82) purified a 15-kDa extracellular GBP from 
S. sobrinus. Wu-Yuan and Gill (188) described a 87-kDa CBP synthesized by S. 
sobrinus B13. Smith et al. (135) reported a 59-kDa GBP of S. mutans. Western 
blot analysis showed that the 87-kDa GBP was antigenically related, but not 
completely identical, to the 74-kDa GBP (188). Smith et al. (135) also 
demonstrated that antiserum to 74-kDa GBP could recognize epitopes on S. 
sobrinus 87-kDa GBP. The 59-kDa GBP did not cross-react with 74-kDa CBP. 
Banas and coworkers (8) have determined the sequence of DNA coding for a 
GBP from S. mutans lngbritt. Interestingly, the molecular mass of the processed 
protein was calculated to be approximately 59 kDa, although the product of the 
gbp clone was shown to react with antisera to the 74-kDa GBP in Western blots. 
These results suggests some structural relationships between GBPs of different 
streptococcal species. 
Although all of these mutans streptococcal GBPs display affinity for glucans 
rich in a-1 ,6-glucosyl linkages, they do not have GTF enzymatic activity. But the 
7 4-kDa GBP from S. mutans was shown to have fructosyltransferase (FTF) 
activity (125). Despite the fact that both FTFs and GBPs synthesize fructans from 
sucrose in S. mutans and show closely simi lar electrophoretic mobilities and 
isoelectric points , the restriction maps of the two genes are distinct, their DNAs 
do not hybridize and there is no immunological cross-reaction between the two 
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proteins (2). There is no report of the fructosyltransferase activity of the other 
GBPs. The relationship between GBP and FTF therefore remains unclear. 
Smith et al. (135) demonstrated that antisera to the 7 4-kDa GBP and to the 
59-kDa GBP of S. mutans reacted weakly with S. mutans and S. sobrinus GTFs 
in Western blot assays. Wu- Yuan and Gill (188) and Russell (9) showed that 
antisera to S. mutans 7 4-kDa GBP cross-reacted with GTFs from S. sobrinus and 
S. downei. Banas and coworkers (8) have determined the sequence of DNA 
coding for a GBP from S. mutans lngbritt. The most striking feature of the 
dedu?ed amino acid sequence was the presence of two sets of repeats that 
spanned three-quarters of the length of the protein. The A repeats were similar to 
the A repeats identified in GTF-1 of S. downei (28) , and the GBP C repeats 
shared partial identity to regions between the A repeats. Both the A and C 
repeats of GBP overlapped reiterated sequences identified by Kuramitsu and 
colleagues within the proteins encoded by gtfB (130) and gtfC (1 68) , although the 
regions homologous to the GBP C repeats were consistently located between 
regions similar to the GBP A repeats. The significance of the 11-amino-acid 
sequence from GTF-1 that is repeated 15 times in GBP with varying degrees of 
identity is uncertain ; however, the beginning of the 11-amino-acid repeats 
coincides with the beginning of the A and C repeat regions. Portions of the GBP 
A repeats were also similar to a repeat region within two pneumococcal 
autolysins. The repeats in autolysins were within the carboxy-terminal portion of 
each protein , and there is evidence that the carboxy-terminal half of each protein 
functions in substrate recognition (39). It would appear that the repeat domains 
have been duplicated and preserved among several genes in different species 
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during evolution , indicating some importance in structure, function, or both. 
When a consensus amino acid sequence of the A repeats of the GBP was 
compared with similar sequences in the GTFs, certain amino acids were found to 
be conserved throughout. These were most often glycine, but a tyrosine-
phenylalanine pair was also conserved. Other amino acids that were conserved 
in almost all instances included threonine , tyrosine, asparagine, glutamine, and 
lysine. All of these amino acids, with the exception of phenylalanine, have been 
reported to be involved in hydrogen bonding in protein-saccharide complexes 
(109) . 
There is some evidence that the GBPs may be involved in the formation of 
cohesive plaque. Russell et al. (125) demonstrated that a GBP-deficient mutant 
of S. mutans forms loosely adherent plaque in vitro. GBPs from S. sobrinus (82) 
and S. cricetus (26) are also thought to contribute to adherence and 
accumulation of the organisms in plaque. The sequencing of the gbp gene has 
laid the foundation on which further experimentation can build an understanding 
of the significance of the repeating regions in GBPs and ultimately of the role of 
the GBP in S. mutans virulence. 
Other organisms that produce capsules may also have GTF- and GBP-like 
proteins. By investigating these proteins and comparing them with GTFs and 
GBPs we may increase understanding of capsule production and provide some 
hints on how to control the diseases caused by these organisms. Therefore, it is 
very important to investigate th is kind of proteins in organisms other than 
streptococci. 
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MATERIALS AND METHODS 
Chemicals 
All chemicals were obtained from Sigma (St Louis, Missouri) unless otherwise 
indicated. 
Mycoplasma 
The SDO strain of Mycoplasma dispar, initially isolated from a pneumonic calf 
(164), was cloned twice and used at passage level of 1 O or 11 . The mycoplasma 
was grown in modified Friis broth (73) with 20% horse serum (HyClone, Logan, 
Utah). 
Preparation of Capsule-coated Agarose-bound RCA120 
RCA120 (agarose-bound Ricinus Communis Agglutinin I, Vector, Burlingame, 
California) bead slurry was washed three times in ice-cold capsule buffer (10 mM 
Hepes pH 8.5 , 0.15 M NaCl, 0.1 mM CaCl2) by centrifuging at 14,000 x g for 3 
minutes at 4°C. Purified capsule (from Dr. Rosenbusch's Lab, Iowa State 
University) was added to the beads and reacted for 1 hour at room temperature 
with tumbling. Then the beads were washed five times in ice-cold capsule buffer 
by centrifugation . 
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Purification of Capsule-Binding Protein 
M. dispar cells were grown in Friis broth with 20% horse serum at 37°C with 
shaking for 19 hours. The mycoplasma cells were harvested from the culture and 
washed three times by centrifugation in PBS at 27,000 x g, for 20 minutes at 4°C. 
Capsule polysaccharide was extracted from the washed cells by incubating in 
PBS at 56°C for 20 minutes. The mycoplasma cells were then recovered by 
centrifugation at 27,000 x g , for 20 minutes at 4°C. The cells were resuspended 
in ice-cold lysis buffer (capsule buffer with 1.5% Triton X-100 , 0.2 mM 
phenylmethylsulfonyl fluoride (PMSF) , and 1 µM leupeptin). The suspension was 
homogenized in a tissue grinder, and DNAase I was added to digest DNA at 4°C 
for 1 hour with tumbling. Non-extractable materials were removed by 
centrifugation at 14,000 x g, for 5 minutes at 4°C. The supernatant was reacted 
with capsule-coated agarose-bound RCA120 for 1 hour at 4°C plus 5 minutes at 
room temperature with tumbling . Then the beads were washed three times in ice-
cold capsule buffer with 0.5% Tween 20 by centrifugation at 14,000 x g, for 3 
minutes 4°C. The washed beads were mixed with the same volume of 2X 
denaturing buffer (final concentration, 0.15 M Tris pH 6.8, 0.8% SOS, 2% 
glycerol, and 0.5% B-2-mercaptoethanol) and boiled 2 minutes before loading the 
gel. Discontinuous PAGE was performed with SOS as described previously by 
Laemmli (81) . The gels were made with 7.5% separating gel and 4% stacking 
gel. A Hoeffer SE 600 series vertical slab unit was used to electrophorese protein 
samples (Hoeffer, San Francisco, California). The protein samples were prepared 
in 40 µI solution , mixed with 40 µI 2X denaturing buffer, and boiled for 2 minutes. 
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Then the protein samples were loaded into the wells of 1.5 mm-thick gels. The 
gels were run at 80 mA (constant current) at room temperature for about 1.5 
hour. A set of known molecular weight standards (molecular weight range 
14,300-220,000, Amersham, Arlington Heights, Illinois) was used to estimate the 
molecular weight of the separated proteins on the SOS-PAGE gels. 
Radiolabeling of Mycoplasma Cells and Purification of Labeled Capsule-
Binding Protein 
To metabolically label mycoplasmas, 20 ml (total protein=1120 µg) of 19 hour 
broth culture was centrifuged at 27,000 x g, for 20 minutes at 20°C. The pellet 
was washed once with labeling medium (Hanks balanced salts solution with 85 
mM Hepes pH7.4, 1 % bovine serum albumin, and 50 µg/ml bacitracin) . The 
pellet was suspended in 4 ml labeling medium with 100 µCi of L-[35S] methionine 
(5 mCi/ml, Amersham, Arlington Heights, Illinois) per ml and incubated at 37°C 
for two hours. The labeling was stopped by adding 20 ml 37°C labeling medium 
with 100 mM unlabeled methionine and incubated at 37°C for 30 minutes. The 
cells were harvested by centri fugation , and washed twice with PBS containing 1 
mM PMSF. The CBP was purified as described above. After electrophoresis, the 
gel was stained in 100 Coomasie Blue with rocking at room temperature 
overnight. The gel was destained with changes of Destain I (50% methanol, 10% 
acetic acid) for 2 hours, and then with Destain II (30% methanol, 3% acetic acid, 
3% glycerine) for 30 minutes. After destaining, the gel was treated with 100 ml 1 
M sodium salycilate for 30 minutes, and then dried in gel dryer. Autoradiography 
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was performed at -70°C using XAR-5 fi lm in casettes with enhancer screens 
(Kodak, Rochester, New York). 
Preparation of Rabbit Antiserum against Capsule-Binding Protein 
M. disparwas grown in 300 ml Friis broth with 20% horse serum at 37°C for 
19 hours. CBP was separated from the cell lysate by following the above 
procedure. Gel slices of 2 mm containing bands separating at 126 kDa were 
obtained from a preparative gel and crushed with 2 ml PBS by extrusion through 
18G and then 20G needles. The crushed gel was injected subcutanously into 
each of two rabbits using 1 ml per rabbit. Booster injections were given three 
times every ten days with the same amount of freshly prepared gel slices. Ten 
days after the fourth inoculation, the rabbits were bled and the serum was 
collected and stored at -20°c . 
Preparation of Globulin Fraction of Rabbit Antiserum 
Equal volume of ice-cold saturated (NH4)2S04 (pH 7.8) was added dropwise 
to ice-cold rabbit serum by stirring constantly. The suspension was stirred 
overnight at 4°C, then centrifuged at 12,100 x g for ten minutes at 4°C. The pellet 
was resuspended to original serum volume in ice-cold saturated (NH4)2S04 (pH 
7.8) diluted 1 :1 with 0.85% NaCl. The suspension was stirred for 1 hour at 4°C 
and centrifuged as above. The pellet was resuspended, stirred, and centrifuged 
again as described above. The pellet was resuspended to 1/5 original serum 
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volume in pH 8.6 TT solution (24 mM Tricine, 81 mM Tris, and 1 mM calcium 
lactate with 0.85% NaCl) and dialyzed against the same solution at 4°C for 72 
hours with 3 changes of dialyzant. The globulin fraction was harvested and stored 
at 4°C with 0.02% sodium azide. 
Triton X-114 Phase Partitioning of Proteins 
Mycoplasmas from 19-hour cultures were subjected to TX-114 phase 
partitioning by a slight modification (121) of the method originally described by 
Bordier (13). Briefly, mycoplasma cells were suspended in Tris-HCI buffer (pH 
7.4) containing 1 % (vol./vol.) precondensed TX-114, 150 mM NaCl, and 1 mM 
PMSF and were incubated at 4°C for 30 minutes. This preparation was 
centrifuged at 4°C for 5 minutes at 10,000 x g to remove insoluble materials. The 
supernatant was transferred to a new tube , incubated at 37°C for 5 minutes, and 
then centrifuged at 22°c for 5 minutes at 10,000 x g. The resulting heavy, 
detergent-enriched fraction (TX-11 4 phase) and a lighter, detergent-depleted 
fraction (aqueous phase) were placed in separate tubes, readjusted to a 
concentration of 1 % (vol./vol.) TX-114, and repartitioned as described above. 
After three cycles of phase fractionation for the detergent phase and for aqueous 
phase, the condensed detergent-enriched phase was used in parallel with the 
aqueous phase for subsequent electrophoresis and immunoblot analysis. 
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Trypsin Treatment of Intact Mycoplasma Cells 
Intact organisms from fresh broth cultures were treated with trypsin by 
variation of a previously described method (72 , 114, 121 ). Briefly, mycoplasmas 
from 19-hour culture were harvested by centrifugation , rinsed twice with PBS (pH 
7.2), then rinsed with PBS (pH 8.0). Cells were incubated at 37°C for 1 hour in 
PBS (pH 8.0) containing varying concentrations of L-1-tosylamide-2-phenylethyl-
chloromethyl ketone-trypsin (TPCK trypsin) per ml. Mycoplasma cells were 
sedimented by centrifugation at 4°C. Pelleted cells were washed twice with PBS 
containing 1 mM PMSF. Then the cells of each concentration of trypsin treatment 
were divided into two equal parts. One part was directly applied to subsequent 
electrophoresis and immunoblot analysis. The other part was lysed with lysis 
buffer as described previously and then reacted with capsule-coated RCA120 
beads. The washed beads were then applied to electrophoresis and immunoblot 
analysis. 
Purification of Binding-domain-bearing Tryptic Digestion Products from the 
Supernatant 
Intact cells were treated by TPCK-trypsin as described above, but only at the 
concentration of 500 µg per ml. Mycoplasmas were spun down at 4°C, and the 
supernatant was collected. After addition of 1 mM PMSF the supernatant was 
divided equally into two parts. One part was concentrated by ultrafiltration on 
30,000 dalton membranes (PM30) (Amicon, Lexington, Massachusetts) to 50 µI, 
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and applied to electrophoresis and immunoblot analysis. The other part was 
reacted with capsule-coated RCA120 beads as described above. Then the 
washed beads were applied to electrophoresis and immunoblot analysis. 
Carboxypeptidase Y Treatment of Intact Mycoplasma Cells 
Intact mycoplasma cells were treated with carboxypeptidase Y following a 
method previously described (58 , 121 ). Briefly, mycoplasmas from a 19-hour 
culture were harvested by centrifugation , rinsed twice with PBS (pH 7.2), then 
rinsed with PBS (pH 6.0). The washed cells were divided equally into two parts. 
One part was incubated at 37°C for 1 hour in PBS (pH 6.0) containing 1 mg/ml 
carboxypeptidase Y (Boehringer Mannheim, Indianapolis, Indiana). The other 
part was set as control. Mycoplasma cells were sedimented by centrifugation at 
4°C. Pelleted cells were washed twice with PBS containing 1 mM PMSF. Then 
the washed cells were applied to etectrophoresis and immunoblot analysis. 
lmmunoblotting 
The western blot technique described previously (1 66) was used to detect 
transferred proteins with some modification. The proteins eletrophoresed on the 
SOS-PAGE gels were transferred onto Zeta-Probe blotting membranes (Bio-Rad, 
Hercules, California) by using an electrotransfer apparatus (Bio-Rad, Hercules, 
California) . Briefly, the gels were rinsed three times for 1 O minutes each in the 
transfer buffer (25 mM sodium phosphate buffer, pH 6.8) without methanol before 
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setting up the sandwich. Transfer was performed at 0.19 A overnight with water 
cooling. After transfer the membrane was incubated in washing buffer (PBS with 
0.1 % Tween 20) at 60°C for 1 hour. Then the membrane was blocked by 
immersion in 5% skim milk in washing buffer at room temperature for 1 hour or at 
4°C overnight with shaking. The membrane was extensively washed three times 
for 15 minutes each with washing buffer at room temperature with shaking. The 
membrane was incubated with 1 :20 polyclonal rabbit-anti-CSP globulin at room 
temperature for 2 hours or at 4°C overnight with shaking and then washed three 
times as above. Peroxidase-conjugated goat-anti-rabbit lgG at 1 :1500 (di luted in 
washing buffer) was added and incubated at room temperature for 2 hours or at 
4°C overnight with shaking. The membrane was again extensively washed as 
above. Enzyme substrate prepared immediately prior to use was poured onto the 
membrane, and incubated at room temperature for about 5 minutes with shaking. 
Reaction was stopped by rinsing the membrane in water. Photography was done 




SOS-PAGE Analysis of L-35S Methionine Labeled Capsule-Binding Protein 
Mycoplasma cells were labeled with L-35S methionine. Proteins captured on 
capsule-coated RCA120 beads were analyzed with SOS-PAGE (Fig. 1 ). Many 
proteins that were labeled could be captured by the capsule-coated RCA120. The 
126 kDa band was prominent and was the largest one. 
lmmunogenicity of Capsule-Binding Protein in Rabbits 
The pooled sera of rabbits injected with purified CBP from M. disparwere 
tested by Western blot analysis for antibody activity (Fig. 2). The antibodies 
reacted with a 126 kDa band. There was also weak reactivity with a 200 kDa 
band , but it disappeared when the dilution of serum was increased. Reactivity 
with the 126 kDa band was detected up to a 1 :320 dilution of the globulin fraction. 
There was no reaction between the sera from the rabbits before immunization 
with CBP (data not shown). The antibodies also reacted with purified CBP 
recognizing only a 126 kDa band (Fig. 3). 
Identification of Capsule-Binding Protein as Integral Membrane Protein 
To evaluate the partitioning characteristics of the CBP , TX-114 phase, 
aqueous phase of fractionated organisms, and whole organisms without 
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fractionation were separated by SOS-PAGE and immunoblot was done with 
antibodies against CBP (Fig. 4). In the TX-114 phase, the 126 kOa protein was 
recognized by the antibodies against CBP and the band was very strong. In the 
aqueous phase, a very faint 126 kOa band was also visualized. This provided 
indication that the CBP was primarily partitioned into the TX-114 phase. 
Surface Location of Capsule-Binding Protein 
To determine if the Capsule-Binding Protein was located on the external 
surface of M. dispar cells, freshly haNested, intact cells were treated with graded 
amounts of TPCK-trypsin. Sets of TPCK-trypsin-treated cells were subjected to 
SOS-PAGE and immunoblotted with antibodies against CBP (Fig. 5). The 
addition of various amounts of TPCK-trypsin resulted in the generation of 
epitope-bearing degradation products with molecular masses of 110 kOa, 100 
kOa, 95 kOa, and 56 kOa. 
Tryptic Digestion Product Bearing Capsule-binding Domain 
CBP was defined by the previous experiment as an integral membrane 
protein. To locate the capsule-binding domain, mycoplasma cells were treated 
with trypsin and then lysed prior to capture of capsule-binding domains on 
capsule-coated RCA120 beads. Capsule-binding domains could only be shown as 
full-length CBP if associated to the mycoplasma cells (Fig. 6). This is evidence 
that trypsin treatment removed the capsule-binding domains from membrane-
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anchored CBP. 
Purification of Capsule-binding Fragments of Capsule-Binding Protein 
The fragments of CBP associated with the mycoplasma cells after trypsin 
digest of the intact mycoplasma cells did not bear the capsule-binding domains. 
Therefore, fragments from the supernatant were examined for capsule-binding 
activity. The supernatant from the trypsin digest of intact mycoplasma cells 
contained bands of 66 kDa, 63 kDa, 61 kDa, 44 kDa, and 39 kDa. Of these , only 
the 66 kDa band was shown to have capsule-binding activity (Fig. 7). The 66 kDa 
bands from total supernatant or capsule-binding fraction of supernatant had the 
same density, indicating that the 66 kDa fragment was totally captured by 
capsule and had no internal trypsin-cleavage sites. There was an unexpectedly 
strong reactivity of the anti-CBP antibody with a 39 kDa fragment that does not 
bear a capsule-binding domain. 
Orientation of Capsule-Binding Protein Anchored in the Membrane 
The orientation of CSP was characterized by digestion of intact organisms 
with carboxypeptidase Y (Fig. 8). The digestion yielded a ladder of epitope-
bearing products with the same spacing, and a minimum size of 60 kDa. 
Figure 1. SOS-PAGE analysis of L-35S methionine labeled M. dispar proteins 
captured on capsule-coated RCA120 beads. Standard molecular weights are 
shown on the left side. The 126 kDa capsule-binding protein is indicated on the 







Figure 2. Western blot analysis of M. dispar reacted with antibodies against CBP. 
The antigens were whole cell proteins {840 µg protein/lane) of M. dispar. 
Dilutions of the antibodies from lane A to lane G were 1:10, 1 :20, 1 :40, 1 :80, 
1 :160, 1 :320, and 1 :640 (1:10 representing 0.7 mg/ml globulins), respectively. 
Standard molecular weights are shown on the left side of the blot. Arrow indicates 
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Figure 3. Western blot analysis of purified CSP reacted with antibodies against 
CBP. The antigen (purified from 840 µg cells/lane) of lane A and lane B was 
purified CBP. The antigen of lane C was capsule-coated RCA120 beads. Antibody 
dilution was 1 :20 (0.35 mg/ml globulins) in lane A, 1 :40 in lane B, and 1 :20 in lane 
C. Standard molecular weights are shown on the left side of the blot. Arrow 

















Figure 4. Western blot analysis of TX-114 phase partitioned M. disparproteins 
with antibody against CSP (partit ions from 1120 µg cell proteins) . Lane A, total M. 
disparproteins ; Lane B, TX-114 phase ; Lane C, aqueous phase. Antibody 
dilution was 1 :20 (0.35 mg/ml globulins). Standard molecular weights are shown 






Figure 5. Western blot analysis of intact mycoplasma cells (equivalent to 1120 µg 
cell protein/lane) treated with TPCK-trypsin. Lane: A, intact cells treated with 10 
µg/ml TPCK-trypsin ; lane B, intact cells treated with 100 µg/ml TPCK-trypsin. 
Antibody dilution was 1 :20 (0.35 mg/ml globulins). Arrows indicate the 126 kDa 
band and the smallest fragment. 
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Figure 6. Western blot analysis of the effects of trypsin treatment of intact 
mycoplasma cells {1120 µg protein/lane) on the capsule-binding property of CBP. 
Lanes A-C, intact cells treated with TPCK-trypsin. Lane A, 1 µg/ml TPCK-trypsin; 
lane B, 10 µg/ml TPCK-trypsin; lane C, 100 µg/ml TPCK. Lanes D-F, intact cells 
treated with TPCK-trypsin , then lysed, and the lysate reacted with capsule-coated 
RCA1 20 beads. Washed beads were loaded on gel. Lane D, CSP from cells 
treated with 1 µg/ml TPCK-trypsin ; lane E, CBP from cells treated with 10 µg/ml 
TPCK-trypsin ; lane F, CSP from cells treated with 100 µg/ml TPCK-trypsin. 
Antibody dilution was 1 :20 (0.35 mg/ml globulins). Standard molecu lar weights 
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Figure 7. Western blot analysis of capsule-binding fragments released into 
supernatant after TPCK-trypsin- treatment of mycoplasma cells . Lane A, total 
supernatant from TPCK-trypsin-treated cells (total cell protein 28 mg); lane B, 
capsule binding protein from supernatant. Antibody dilution was 1 :20 (0.35 mg/ml 






Figure 8. Carboxypeptidase Y analysis of CBP orientation on M. disparcell 
membrane by Western blot with antibody against CBP (total protein 2240 µg);. 
Lane A, intact mycoplasma cells; lane B, mycoplasma cells treated with 
carboxypeptidase Y. Antibody dilution was 1 :20 (0.35 mg/ml globulins). The 126 
kDa protein and the smallest fragment were indicated on the right side. Standard 








Mycoplasma dispar can produce capsular polysaccharide, which exerts 
inhibitory effects on host immune response. CBP was found to bind the capsule 
and to be co-regulated with its production, and may therefore be associated with 
capsule production . Glucosyltransferases (GTFs) of mutans streptococci have 
been demonstrated to have glucan-binding and catalytic domains and be very 
important virulence factors (53, 93, 94, 109). M. dispar CBP may share some 
biological and structural properties with GTFs. This study used TX-114 detergent-
phase fractionation to demonstrate hydrophobic domains within CBP, thereby 
categorizing CBP as an integral membrane protein . It further established that 
CBP is oriented with the C-terminus exposed externally to the single bilayer 
membrane of the organism and the capsule-binding domain is located in a 66 
kDa tryptic fragment which appears to be at or near the C-terminal end. 
To determine if CBP is an integral membrane protein in this study, a 
combination of polyclonal serum against CBP and application of TX-114 phase 
partitioning system was used. Membrane proteins are usually divided in two 
categories: integral proteins and peripheral proteins (132). The majority, integral 
proteins, are intercalated more or less deeply into or even through the lipid 
double layer and are held in position by strong, mostly hydrophobic interactions 
between hydrophobic amino acid side chains and lipid hydrocarbon chains. For 
identification of integral membrane proteins the Triton X-114 phase fractionation 
method has been suggested by some authors (13, 16, 114). Detergent phase 
partitioning has gained wide acceptance in selectively fractionating proteins 
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associated with a number of membrane systems (108). Two particular 
advantages, however, underscore the unique applicability of this technique to the 
study of mycoplasma membrane proteins. First, unlike eubacteria and 
eucaryotes, mycoplasmas have only a single plasma membrane system which is 
essentially responsible for all communication of these organisms with their 
external environment. As a result , proteins identified during phase partitioning by 
their intrinsic property of hydrophobicity are selected as components likely to be 
associated with this single membrane system. It is therefore an efficient method 
to focus on a group of mycoplasma components having probable roles in 
important membrane functions. Second, it is generally established that with the 
notable exception of acholeplasma, most mycoplasmas yield membrane 
preparations by standard disruption procedures that are significantly 
contaminated with intracellular and extracellular macromolecules (110). The use 
of TX-114 phase partitioning is perhaps ideally suited, therefore, for the 
segregation of mycoplasma membrane proteins from these contaminants. TX-
114 phase partitioning of CBP resulted in most of the CBP being found in the TX-
114 phase. This identified that the CBP has hydrophobic domains and defined 
CBP as an integral membrane protein. For the integral membrane proteins, there 
is a range of hydrophobicities, from those having only one putative hydrophobic 
transmembrane segment to those having several to many segments, in relation 
to the lengths of the proteins and their hydrophilic parts. Since some CBP was 
also found in the aqueous phase, further analysis will need to be done to 
understand the structure of CBP. 
Because of the possibility raised by this study that the CBP could be a surface 
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exposed protein, further delineation of the orientation and molecular location was 
sought. Trypsin (which cleaves predominantly at Lys and Arg residues) has been 
used extensively in many systems to demonstrate surface proteins on intact cells 
(61 , 114, 121 ). The CBP was established to be exposed at the mycoplasma 
surface, since it was susceptible to the action of trypsin on intact organisms, 
which removed all capsule-binding cleavage fragments from membrane 
association. 
In addition to the 1 26 kDa band, there were two other bands > 126 kDa shown 
in Fig. 2, 4, 6, 8. The possible reason for why the antibodies against CBP also 
reacted with other large proteins is that when we made CBP antigens, some 
degraded 126 kDa fragment from the large proteins was also contained in the gel 
slices. In the TX-114 partitioning experiment, the proteins larger than 126 kDa did 
not appear in the TX-1 14 phase. This would indicate these proteins are not 
membrane related. Nonspecific reactivity of antibodies against CBP may also 
account for results. For instance, the 39 kDa fragment produced a very strong 
band compared to others. One possible reason is that several fragments of 
similar size were generated from more than one protein species. 
Large proteins are organized in domains (66) , in part because this aids protein 
three-dimensional assembly during protein synthesis. Protein folding is more 
manageable when it occurs in discrete segments, which minimizes 
thermodynamic and steric complexities of assembling a large random structure 
(181 ). There are evolutionary advantages to domain structure as well. Protein 
segments which can maintain native form and function independently of external 
stabilizing forces have fewer structural demands when incorporated into a new 
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protein through recombination (66). Therefore , the CBP of M. dispar is supposed 
to have structural domains. Intact CBP has the capacity to bind M. dispar 
capsule. This suggests that M. dispar CBP has capsule-binding domains. Mild 
trypsin digestion of intact M. disparcells generates several large fragments that 
are associated with the mycoplasma cells, but none of these fragments have the 
capacity to bind M. dispar capsule. A single 66 kDa fragment from the 
supernatant displays capsule-binding function equivalent to that of the intact 
CBP. This fragment appears to contain the full size of the capsule binding 
domain. Kobayashi et al. (81 ) reported a 55-kDa glucan-binding fragment from 
GTF-S and GTF-1 of Streptococcus sobrinus after proteolysis, and Mooser and 
Wong reported a 60-kDa glucan-binding fragment. Size similarity among these 
fragments may underscore other similarities. The binding domain of M. dispar 
CBP may have similar repeating structures as those of the GTFs of mutans 
streptococci . To confirm this, amino acid sequence analysis of the 66-kDa 
fragment will be needed. 
Integral membrane proteins can be divided into four classes according to their 
topology in the membrane (174, 175). Class I proteins have a cleavable N-
terminal signal peptide followed by a hydrophilic loop and a hydrophobic anchor 
sequence. The latter is followed by a cluster of positively charged amino acids, 
and the final orientation of processed proteins is N terminus out/C terminus in. 
Class II proteins have an uncleaved signal peptide acting as an anchor, giving 
the proteins an N terminus in/C terminus out topology. Class Il l proteins are 
similar to Class II proteins, but have an N terminus out/C terminus in orientation 
due to presence of positive clusters after the anchor segment. Class IV proteins 
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have multiple hydrophobic regions spanning the membrane. The M. disparCBP 
appears to belong to Class II, because it was demonstrated that CBP had a N 
terminus in/C terminus out topology. Carboxypeptidase Y can successively 
cleave C-terminal amino acid residues and hydrolyses Lys , Arg , and His residues 
at greatly reduced relative rates (58). Digestion of intact M. di spar cells with 
carboxypeptidase Y yielded a ladder with a minimum size of 60 kDa. The spacing 
of the products was the same. This result suggested that the C-terminal portion of 
CBP is accessible at the external surface of the organism. In addition , it also 
suggested that CSP is not anchored in the membrane by C-terminal regions, but 
rather is anchored by the N-terminal portion of the molecule. In the result , the 
generated fragment bands were weak and most of the CBPs were not digested. 
One possible reason may be that the capsule-releasing step did not release most 
of the capsules. Therefore , capsule protected the CBP from being digested. 
We have shown that M. dispar CBP is an integral membrane protein with its 
N-terminal portion anchored in the membrane and C-terminus external and its 
capsule-binding domain is located at or near the C-terminal region. Detailed 
structural and functional analysis of M. dispar CBP with emphasis on its role in 
capsule production and its interaction with the capsule will give insights into the 
understanding of capsule synthesis mechanism and may lead to the development 
of a vaccine to control the disease caused by M. dispar. The results presented 
here also provide the necessary basis for further studies of M. disparCBP . 
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